Entera Bio (ENTX) Tax Provisions (2021 - 2024)

Entera Bio (ENTX) recorded quarterly Tax Provisions of $14000.0 in Q4 2024, down 51.72% on a QoQ basis from $29000.0 in Q3 2023.

Entera Bio (ENTX) Tax Provisions (2021 - 2024) Analysis & Trends

Entera Bio has disclosed Tax Provisions across 4 years of filings, most recently posting $14000.0 for Q4 2024.

Quarterly Tax Provisions changed N/A year-over-year to $14000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $43000.0 (up 48.28% YoY) and the FY2024 annual result came in at $14000.0, down 51.72% from the prior year.
Tax Provisions retreated to $14000.0 in Q4 2024, from $29000.0 in the prior quarter.
Over five years, Tax Provisions peaked at $194000.0 in Q3 2022 and troughed at -$46000.0 in Q4 2022.
A 4-year average of $12100.0 and a median of -$10000.0 in 2021 frame the typical range for Tax Provisions.
Biggest YoY gain for Tax Provisions was 1592.31% in 2022; the steepest drop was 206.67% in 2022.
Tracing ENTX's Tax Provisions over 4 years: stood at -$15000.0 in 2021, then tumbled by 206.67% to -$46000.0 in 2022, then jumped by 163.04% to $29000.0 in 2023, then plunged by 51.72% to $14000.0 in 2024.
Business Quant data shows ENTX's Tax Provisions at $14000.0 in Q4 2024, $29000.0 in Q3 2023, and -$46000.0 in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-	-
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-	-
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-	-
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn	-11.20 Mn
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-	-859,000.00
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-	216,000.00
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-	-
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn	221.50 Mn
9	Abivax	94.37 Bn	94.37 Bn	-	-
10	Entera Bio	56.59 Mn	52.45 Mn	-	-

Download Data